Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Timolol

A non-selective beta blocker patented in 1968: it is also taken by mouth for high blood pressure, but is best known as eye drops that lower the pressure inside the eye in glaucoma. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?In 1978 it became the first beta blocker approved in the United States for application directly to the eye, as drops, to treat glaucoma.

TimololGo to the active ingredient →
TimololActive ingredientTimololCat. No. P-T123-001CAS 26839-75-8

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.